Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin
Nan Xu,Siqi Liu,Yongqiang Zhang,Yujing Chen,Yumei Zuo,Xiaoqiu Tan,Bin Liao,Pengyun Li,Jian Feng,Nan XuSiqi LiuYongqiang ZhangYujing ChenYumei ZuoXiaoqiu TanBin LiaoPengyun LiJian Fenga Department of Cardiology,The First People's Hospital of Neijiang,Neijiang,People's Republic of Chinab Department of Cardiology,The Affiliated Hospital of Southwest Medical University,Key Laboratory of Medical Electrophysiology,Ministry of Education and Medical Electrophysiological Key Laboratory of Sichuan Province,Institute of Cardiovascular Research,Southwest Medical University,Luzhou,People's Republic of Chinac Department of Cardiovascular Surgery,The Affiliated Hospital of Southwest Medical University,Metabolic Vascular Diseases Key Laboratory of Sichuan Province,Luzhou,People's Republic of China
DOI: https://doi.org/10.1080/13510002.2023.2246720
2023-09-25
Redox Report
Abstract:Diabetes mellitus (DM) is one of the most prevalent metabolic disorders that poses a global threat to human health. It can lead to complications in multiple organs and tissues, owing to its wide-ranging impact on the human body. Diabetic cardiomyopathy (DCM) is a specific cardiac manifestation of DM, which is characterized by heart failure in the absence of coronary heart disease, hypertension and valvular heart disease. Given that oxidative stress is a key factor in the pathogenesis of DCM, intervening to mitigate oxidative stress may serve as a therapeutic strategy for managing DCM. Naringenin is a natural product with anti-oxidative stress properties that can suppress oxidative damage by regulating various oxidative stress signaling pathways. In this review, we address the relationship between oxidative stress and its primary signaling pathways implicated in DCM, and explores the therapeutic potential of naringenin in DCM.
biochemistry & molecular biology